United Therapeutics.

United Therapeutics is building a $500 million manufacturing facility near its existing operations to expand production of a drug-device combination product that received approval by the U.S. Food and Drug Administration last year. The product, Tyvaso DPI...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT